Caseware UK (AP4) 2021.0.152 2021.0.152 2022-03-312022-03-312021-04-01truetrueInvestment holding company3false 13026707 2021-03-31 13026707 2021-04-01 2022-03-31 13026707 2020-04-01 2021-03-31 13026707 2022-03-31 13026707 c:Director2 2021-04-01 2022-03-31 13026707 d:CurrentFinancialInstruments 2022-03-31 13026707 d:CurrentFinancialInstruments d:WithinOneYear 2022-03-31 13026707 d:ShareCapital 2022-03-31 13026707 c:EntityHasNeverTraded 2021-04-01 2022-03-31 13026707 c:FRS102 2021-04-01 2022-03-31 13026707 c:AuditExempt-NoAccountantsReport 2021-04-01 2022-03-31 13026707 c:FullAccounts 2021-04-01 2022-03-31 13026707 c:PrivateLimitedCompanyLtd 2021-04-01 2022-03-31 13026707 6 2021-04-01 2022-03-31 iso4217:GBP xbrli:pure
Registered number: 13026707






CVS INVESTMENTS 1 LIMITED
UNAUDITED
FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2022










img6bc5.png

 
CVS INVESTMENTS 1 LIMITED
REGISTERED NUMBER:13026707

BALANCE SHEET
AS AT 31 MARCH 2022

2022
Note
£

Fixed assets
  

Investments
  
100

  
100

Current assets
  

Debtors: amounts falling due within one year
  
100

  
100

Creditors: amounts falling due within one year
  
(100)

Net current assets
  
 
 
-

Total assets less current liabilities
  
100

  

Net assets
  
100


Capital and reserves
  

Called up share capital 
  
100

  
100


For the period ended 31 March 2022 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 


D Ellis
Director

Date: 15 August 2022

Page 1

 
CVS INVESTMENTS 1 LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2022

1.


General information

CVS Investments 1 Limited is a private company limited by shares incorporated in England and Wales. The registered office is Millhouse, 32-38 East Street, Rochford, Essex, SS4 1DB. 
The company was incorporated on 17 November 2020, its principal activity being that of an investment holding company.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

 
2.2

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Profit and Loss Account for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.3

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.4

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and Loss Account.

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Page 2

 
CVS INVESTMENTS 1 LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2022

3.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


Additions
100



At 31 March 2022
100





4.


Debtors

2022
£


Amounts owed by group undertakings
70

Other debtors
30

100



5.


Creditors: Amounts falling due within one year

2022
£

Other creditors
100

100


Page 3